reported that the sensitivity of DNA methylation of 4 genes (NDRG4, BMP3, TFPI2, vimentin) for patients with CRC and in patients with advanced adenomas (AA) (>1 cm) patients was 85% and 54%, respectively, and the specificity was 90% (16). The gene discussed is TFPI2; the disease is colorectal carcinoma.